Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-25 Purchase | 2021-05-25 9:45 pm | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 1,000 | $5.29 | $5,290 | 202,001 (Direct) | View |
| 2020-12-24 Purchase | 2020-12-28 06:21 am | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 1,000 | $7.38 | $7,380 | 101,001 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-23 Option Award | 2022-12-28 9:45 pm | N/A 2027-12-23 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 200,000 | $0.48 | 500,001 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 6:50 pm | N/A 2027-02-25 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 50,000 | $3.27 | 50,000 (Direct) | View |
| 2021-03-12 Option Award | 2021-09-02 9:27 pm | N/A 2026-03-12 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 200,001 | $7.5 | 252,001 (Direct) | View |
| 2021-08-31 Option Award | 2021-09-02 9:27 pm | N/A 2026-08-31 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 50,000 | $5.26 | 252,001 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-17 8:48 pm | N/A 2026-03-12 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 100,000 | $7.5 | 201,001 (Direct) | View |
Ownership | 2020-12-10 9:52 pm | N/A 2023-10-22 | Vivos Therapeutics Inc. | VVOS | Amman Bradford K. Chief Financial Officer | 0 | $0 | 100,001 (Direct) | View |